Carna Biosciences (TSE:4572) Other Financing: 円0.0 Mil (TTM As of Dec. 2025)


TSE:4572 Carna Biosciences Inc TSE:4572
34 GF Score
Price 円339.00
GF Value 円188.38
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences Other Financing?

Carna Biosciences TSE:4572 -2.87% 34 Other Financing is 円0.0 Mil as of Dec. 2025. GuruFocus rates TSE:4572 with a GF Score™ of 34/100 and a GF Value™ of 円188.38 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Carna Biosciences's Other Financing for the three months ended in Dec. 2025 was 円0.0 Mil.

Carna Biosciences's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.0 Mil.

Carna Biosciences Other Financing Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences Other Financing Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.64 5.71 -9.29 687.44 -8.12

Carna Biosciences Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4572
34GF Score
Carna Biosciences Inc TSE:4572
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of 円0.0 Mil mean?
Carna Biosciences (TSE:4572) has a Other Financing of 円0.0 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Carna Biosciences and its competitors.
Is Carna Biosciences' Other Financing too high?
Carna Biosciences' current Other Financing is 円0.0 Mil. Overall, Carna Biosciences has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Other Financing compare to VRTX and REGN?
Carna Biosciences' Other Financing of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Biotechnology company?
A good Other Financing depends on the Biotechnology industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Carna Biosciences and its competitors. Carna Biosciences's current Other Financing is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円188.38, compared to a current price of 円339.00 — trading 80% above its estimated fair value. The current Other Financing is 円0.0 Mil. Carna Biosciences' overall GF Score™ is 34/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Other Financing is 円0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円339.00 is trading 80% above its estimated GF Value™ of 円188.38. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • Other Financing: 円0.0 Mil
  • GF Value™: 円188.38 vs. price of 円339.00 (80% above fair value)
  • GF Score™: 34/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
34GF Score

Get the complete analysis for TSE:4572

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円339.00
Price
円188.38
GF Value